Bausch Health Companies Inc. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
Bausch Health Companies Inc. (BHC) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $1.97 billion for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-08-10
- Bausch Health Companies Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $1.97B, a 5.35% decline year-over-year.
- Bausch Health Companies Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.13B, a 9.92% decline year-over-year.
- Bausch Health Companies Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.19B, a 10.52% decline year-over-year.
- Bausch Health Companies Inc. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $2.20B, a 7.91% decline year-over-year.
- Bausch Health Companies Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $8.05B, a 42.65% increase from fiscal 2013.
- Bausch Health Companies Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2013 was $5.64B, a 71.51% increase from fiscal 2012.
- Bausch Health Companies Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2012 was $3.29B, a 45.83% increase from fiscal 2011.
- Bausch Health Companies Inc. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2011 was $2.26B, a 98.97% increase from fiscal 2010.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $1.97B 10-Q · filed 2018-05-08 | $4.10B derived: sum of 2 quarters · filed 2018-08-10 | $6.28B derived: sum of 3 quarters · filed 2018-08-10 | $8.48B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-12-31 | $2.13B derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $4.32B derived: sum of 2 quarters · filed 2018-08-10 | $6.52B derived: sum of 3 quarters · filed 2018-08-10 | $8.60B 8-K · filed 2018-08-10 | ||||
| 2017-09-30 | $2.19B 10-Q · filed 2017-11-07 | $4.39B derived: sum of 2 quarters · filed 2017-11-07 | $6.46B 10-Q · filed 2017-11-07 | $8.83B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-06-30 | $2.20B 10-Q · filed 2017-08-08 | $4.28B 10-Q · filed 2017-08-08 | $6.64B derived: sum of 3 quarters · filed 2018-08-10 | $9.09B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $2.08B 10-Q · filed 2018-05-08 | $4.44B derived: sum of 2 quarters · filed 2018-08-10 | $6.89B derived: sum of 3 quarters · filed 2018-08-10 | $9.28B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2016-12-31 | $2.37B derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $4.81B derived: sum of 2 quarters · filed 2018-08-10 | $7.20B derived: sum of 3 quarters · filed 2018-08-10 | $9.54B 8-K · filed 2018-08-10 | ||||
| 2016-09-30 | $2.44B 10-Q · filed 2017-11-07 | $2.44B 10-Q · filed 2016-11-09 | $4.83B derived: sum of 2 quarters · filed 2017-11-07 | $7.17B 10-Q · filed 2017-11-07 | $7.17B 10-Q · filed 2016-11-09 | $9.89B derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-06-30 | $2.39B 10-Q · filed 2017-08-08 | $2.39B 10-Q · filed 2016-08-09 | $4.72B 10-Q · filed 2017-08-08 | $4.72B 10-Q · filed 2016-08-09 | $7.45B derived: sum of 3 quarters · filed 2018-08-10 | $10.20B derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-03-31 | $2.34B 10-Q · filed 2017-05-09 | $2.34B 10-Q · filed 2016-06-07 | $5.06B derived: sum of 2 quarters · filed 2018-08-10 | $7.81B derived: sum of 3 quarters · filed 2018-08-10 | $10.50B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $2.72B derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $5.47B derived: sum of 2 quarters · filed 2018-08-10 | $8.17B derived: sum of 3 quarters · filed 2018-08-10 | $10.29B 8-K · filed 2018-08-10 | $10.29B 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $2.75B 10-Q · filed 2016-11-09 | $5.44B derived: sum of 2 quarters · filed 2016-11-09 | $7.57B 10-Q · filed 2016-11-09 | $7.59B 10-Q · filed 2015-10-26 | $9.75B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $2.69B 10-Q · filed 2016-08-09 | $4.82B 10-Q · filed 2016-08-09 | $4.84B 10-Q · filed 2015-07-28 | $7.00B derived: sum of 3 quarters · filed 2017-03-01 | $9.02B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $2.13B 10-Q · filed 2016-06-07 | $2.15B 10-Q · filed 2015-04-30 | $4.30B derived: sum of 2 quarters · filed 2017-03-01 | $6.33B derived: sum of 3 quarters · filed 2017-03-01 | $8.32B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $2.18B derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $4.20B derived: sum of 2 quarters · filed 2017-03-01 | $6.19B derived: sum of 3 quarters · filed 2017-03-01 | $8.05B 10-K · filed 2017-03-01 | $8.10B 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $2.02B 10-Q · filed 2015-10-26 | $4.02B derived: sum of 2 quarters · filed 2015-10-26 | $5.87B 10-Q · filed 2015-10-26 | $7.90B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $1.99B 10-Q · filed 2015-07-28 | $3.85B 10-Q · filed 2015-07-28 | $5.88B derived: sum of 3 quarters · filed 2016-04-29 | $7.38B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $1.85B 10-Q · filed 2015-04-30 | $3.88B derived: sum of 2 quarters · filed 2016-04-29 | $5.39B derived: sum of 3 quarters · filed 2016-04-29 | $6.45B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $2.03B derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $3.54B derived: sum of 2 quarters · filed 2016-04-29 | $4.60B derived: sum of 3 quarters · filed 2016-04-29 | $5.64B 10-K · filed 2016-04-29 | $5.64B 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $1.51B 10-Q · filed 2014-10-24 | $1.51B 10-Q · filed 2013-11-01 | $2.57B derived: sum of 2 quarters · filed 2014-10-24 | $3.61B 10-Q · filed 2014-10-24 | $3.61B 10-Q · filed 2013-11-01 | $4.55B derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $1.06B 10-Q · filed 2014-08-01 | $1.06B 10-Q · filed 2013-08-07 | $2.10B 10-Q · filed 2014-08-01 | $2.10B 10-Q · filed 2013-08-07 | $3.04B derived: sum of 3 quarters · filed 2015-02-25 | $3.90B derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $1.04B 10-Q · filed 2014-05-09 | $1.04B 10-Q · filed 2013-05-03 | $1.98B derived: sum of 2 quarters · filed 2015-02-25 | $2.83B derived: sum of 3 quarters · filed 2015-02-25 | $3.58B derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $942.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $1.79B derived: sum of 2 quarters · filed 2015-02-25 | $2.54B derived: sum of 3 quarters · filed 2015-02-25 | $3.29B 10-K · filed 2015-02-25 | $3.31B 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $852.75M 10-Q · filed 2013-11-01 | $856.89M 10-Q · filed 2012-11-05 | $1.60B derived: sum of 2 quarters · filed 2013-11-01 | $2.35B 10-Q · filed 2013-11-01 | $2.36B 10-Q · filed 2012-11-05 | $3.00B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-06-30 | $742.97M 10-Q · filed 2013-08-07 | $748.74M 10-Q · filed 2012-08-03 | $1.49B 10-Q · filed 2013-08-07 | $1.51B 10-Q · filed 2012-08-03 | $2.15B derived: sum of 3 quarters · filed 2014-02-28 | $2.72B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-03-31 | $750.88M 10-Q · filed 2013-05-03 | $768.38M 10-Q · filed 2012-05-04 | $1.41B derived: sum of 2 quarters · filed 2014-02-28 | $1.98B derived: sum of 3 quarters · filed 2014-02-28 | $2.51B derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2011-12-31 | $654.17M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.22B derived: sum of 2 quarters · filed 2014-02-28 | $1.75B derived: sum of 3 quarters · filed 2014-02-28 | $2.26B 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $570.42M 10-Q · filed 2012-11-05 | $1.10B derived: sum of 2 quarters · filed 2012-11-05 | $1.60B 10-Q · filed 2012-11-05 | $2.09B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $530.03M 10-Q · filed 2012-08-03 | $1.03B 10-Q · filed 2012-08-03 | $1.52B derived: sum of 3 quarters · filed 2013-02-28 | $1.72B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $500.42M 10-Q · filed 2012-05-04 | $989.14M derived: sum of 2 quarters · filed 2013-02-28 | $1.19B derived: sum of 3 quarters · filed 2013-02-28 | $1.42B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $488.72M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $690.09M derived: sum of 2 quarters · filed 2013-02-28 | $921.34M derived: sum of 3 quarters · filed 2013-02-28 | $1.13B 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $201.37M 10-Q · filed 2011-11-04 | $432.62M derived: sum of 2 quarters · filed 2011-11-04 | $644.65M 10-Q · filed 2011-11-04 | $876.28M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | $231.25M 10-Q · filed 2011-08-08 | $443.28M 10-Q · filed 2011-08-08 | $674.90M derived: sum of 3 quarters · filed 2012-02-29 | $879.20M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | $212.03M 10-Q · filed 2011-05-10 | $443.66M derived: sum of 2 quarters · filed 2012-02-29 | $647.95M derived: sum of 3 quarters · filed 2012-02-29 | $835.67M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $231.63M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $435.92M derived: sum of 2 quarters · filed 2012-02-29 | $623.63M derived: sum of 3 quarters · filed 2012-02-29 | $789.03M 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $204.29M 10-Q · filed 2010-11-05 | $392.01M derived: sum of 2 quarters · filed 2010-11-05 | $557.40M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $187.72M 10-Q · filed 2010-08-06 | $353.11M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | $714.55M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |